Tags

Type your tag names separated by a space and hit enter

Review of guidelines and the literature in the treatment of acute bronchospasm in asthma.
Pharmacotherapy. 2006 Sep; 26(9 Pt 2):148S-55S.P

Abstract

Asthma is a common chronic condition that disproportionately affects persons younger than 45 years. Asthma exacerbations can be sudden and severe, requiring treatment in the emergency department or hospitalization. Children younger than 15 years are 2-4 times more likely to have asthma as the first-listed hospital discharge diagnosis compared with those in other age groups. An estimated 12.8 million missed school days and 24.5 million lost work days due to asthma occurred in 2003. Drugs used in the treatment of acute asthma include inhaled beta(2)-agonists, oral corticosteroids, and inhaled anticholinergics. Levalbuterol was evaluated in several recent trials for treatment of asthma in the emergency department, for its effect in improving pulmonary function and on hospitalization rate. Theophylline, intravenous beta(2)-agonists, intravenous magnesium sulfate, and inhaled anesthetics have not been proven useful in the emergency management of asthma. The effectiveness of inhalation devices is dependent on age, cooperation of the patient, and technique.

Authors+Show Affiliations

Center for Clinical Pediatric Pharmacology Research, Nemours Children's Clinic, Jacksonville, Florida 32247, USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

16945061

Citation

Blake, Kathryn. "Review of Guidelines and the Literature in the Treatment of Acute Bronchospasm in Asthma." Pharmacotherapy, vol. 26, no. 9 Pt 2, 2006, 148S-55S.
Blake K. Review of guidelines and the literature in the treatment of acute bronchospasm in asthma. Pharmacotherapy. 2006;26(9 Pt 2):148S-55S.
Blake, K. (2006). Review of guidelines and the literature in the treatment of acute bronchospasm in asthma. Pharmacotherapy, 26(9 Pt 2), 148S-55S.
Blake K. Review of Guidelines and the Literature in the Treatment of Acute Bronchospasm in Asthma. Pharmacotherapy. 2006;26(9 Pt 2):148S-55S. PubMed PMID: 16945061.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Review of guidelines and the literature in the treatment of acute bronchospasm in asthma. A1 - Blake,Kathryn, PY - 2006/9/2/pubmed PY - 2007/1/11/medline PY - 2006/9/2/entrez SP - 148S EP - 55S JF - Pharmacotherapy JO - Pharmacotherapy VL - 26 IS - 9 Pt 2 N2 - Asthma is a common chronic condition that disproportionately affects persons younger than 45 years. Asthma exacerbations can be sudden and severe, requiring treatment in the emergency department or hospitalization. Children younger than 15 years are 2-4 times more likely to have asthma as the first-listed hospital discharge diagnosis compared with those in other age groups. An estimated 12.8 million missed school days and 24.5 million lost work days due to asthma occurred in 2003. Drugs used in the treatment of acute asthma include inhaled beta(2)-agonists, oral corticosteroids, and inhaled anticholinergics. Levalbuterol was evaluated in several recent trials for treatment of asthma in the emergency department, for its effect in improving pulmonary function and on hospitalization rate. Theophylline, intravenous beta(2)-agonists, intravenous magnesium sulfate, and inhaled anesthetics have not been proven useful in the emergency management of asthma. The effectiveness of inhalation devices is dependent on age, cooperation of the patient, and technique. SN - 0277-0008 UR - https://www.unboundmedicine.com/medline/citation/16945061/Review_of_guidelines_and_the_literature_in_the_treatment_of_acute_bronchospasm_in_asthma_ L2 - https://doi.org/10.1592/phco.26.9part2.148S DB - PRIME DP - Unbound Medicine ER -